QA: Monopar Therapeutics in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001645469_2022_Monopar_Therapeutics.pdf

Logs

info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001645469')"}

Graph

Absolute values for 0001645469, Monopar Therapeutics

  xvar xval
0 AssetsCurrent 20,521,614
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 0
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 1,580,543
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,634,040
9 ResearchAndDevelopmentExpense 6,493,208
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 24,024
13 remainder_ComprehensiveNetIncome 4,713
  yvar yval
0 Assets 20,521,614
1 Liabilities 1,580,543
2 Expenses 9,127,248
3 Revenues 0
4 StockholdersEquity 18,941,071
5 NetIncome -9,103,224
6 ComprehensiveNetIncome -9,100,868
7 BaseVar 15,629,071
8 EconomicCapitalRatio 2.12

Edgar->Model Mapping

Feature Distribution

Change over Time